Plainfield, IL, United States of America

Anita Mehta

This inventor holds 23 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Muscarinic Receptor Antagonists. Top assignees: Ranbaxy Laboratories, Inc., Aegis Industries, Inc.. Active years: 2000-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anita Mehta. Retrieved from https://idiyas.com/inventor/anita-mehta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 

% Patents Active = 30.4


Average Co-Inventor Count = 4.3

ph-index = 6

Forward Citations = 132(Granted Patents)


Location History:

  • Gurgaon, IN (2000 - 2004)
  • Haryana, IN (2004 - 2005)
  • Buffalo Grove, IL (US) (2008 - 2009)
  • Plainfield, IL (US) (2007 - 2012)

Company Filing History:


Years Active: 2000-2012

Loading Chart...
Loading Chart...
Areas of Expertise:
Electromuscular Incapacitation
Muscarinic Receptor Antagonists
Azabicyclo Derivatives
Antimicrobials
Flavaxate Derivatives
Piperazinyl Derivatives
Hexane Derivatives
Uro-Selective Blockers
23 patents (USPTO):Explore Patents

Title: Innovative Contributions of Anita Mehta in Electromuscular Devices

Introduction

Anita Mehta, an accomplished inventor based in Plainfield, IL, has significantly contributed to the field of electromuscular applications with a remarkable portfolio of 23 patents. Her inventions, particularly focused on devices for incapacitation using electric waveforms, highlight her expertise and innovative spirit in enhancing safety and control technologies.

Latest Patents

Mehta's latest patents include groundbreaking work on an electromuscular incapacitation device. This device operates by applying a pulsed, low-power electric waveform to a mammalian subject, inducing involuntary muscular contractions. The waveform is applied at a specific frequency and duration, resulting in minimal lactic acid production, ensuring that the process is non-injurious or minimally injurious to the subject's tissues. This technology is designed to effectively control or subdue individuals in critical situations, marking a significant advancement in safety devices.

Career Highlights

Throughout her career, Anita Mehta has been affiliated with notable companies, including Ranbaxy Laboratories and Aegis Industries. Her work in these organizations has been instrumental in the development and commercialization of various innovative technologies in the medical and safety sectors.

Collaborations

Mehta has collaborated with distinguished professionals in her field, including Jang Bahadur Gupta and Arundutt Viswanatham Silamkoti. These partnerships have enriched her research and development processes, leading to enhanced outcomes in her inventive projects.

Conclusion

Anita Mehta's contributions to electromuscular incapacitation technologies exemplify her pioneering spirit and dedication to innovation. With a strong portfolio of patents, she continues to push the boundaries of what is possible in the realm of safety and control devices, establishing herself as a key player in the industry. Her work not only advances technological capabilities but also opens up new avenues for application in various sectors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…